
Ocular Therapeutix
Biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye.
Market cap
$1.5b
Enterprise value
$1.2b
Share price
$9.28 OCUL
Authorizing premium user...